SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Axiom Intelligence Acquisition Corp 1 entered into a business combination agreement with Terra Quantum AG dated May 25, 2026. The transaction will result in Terra Quantum becoming …
Elmet Group achieved strong Q1 2026 results with revenue increasing 20.7% to $56.0 million and adjusted EBITDA doubling to $9.2 million, driven by aerospace and defense demand. The…
XCF Global is issuing 13.3 million common shares for $2 million in a private placement under Regulation D exemption. The company plans to register resale rights in connection with …
CoStar Realty Information entered into a stock purchase agreement dated May 28, 2026 to acquire assets from Bora Holdings Group and Bora Inc. The transaction represents CoStar's co…
Science Applications International Corp announced a cash dividend of $0.37 per share with a record date of July 10, 2026, demonstrating the company's commitment to returning capita…
Aptose Biosciences announced that closing of its previously announced Plan of Arrangement with Hanmi Pharmaceutical has been further delayed due to pending Korean regulatory approv…
Johnson Outdoors' Board approved a quarterly cash dividend of $0.33 per Class A share and $0.30 per Class B share, payable July 30, 2026. The dividend announcement reflects the com…
EDAP TMS SA announced a corporate name change to FocalTherics and ticker symbol change from EDAP to FOCL, effective June 1, 2026, to reflect its strategic focus on robotic focal th…
Genesco reported Q1 FY2027 net sales of $487M (+3% YoY) with seven consecutive quarters of positive comparable sales growth, driven by strong Journeys (+5%) and Johnston & Murphy (…
Picard Medical achieved $1.2M in Q1 2026 revenue with 24% gross margins and reduced debt by $9.5M. The artificial heart maker is making progress toward profitability after its 2025…
Silexion Therapeutics completed a 1-for-10 reverse share split to maintain compliance with Nasdaq Capital Market minimum bid price listing requirements. The consolidation reduces o…
Nano Nuclear Energy Inc. executed a membership interest purchase agreement dated May 22, 2026 with Roy A. Boyd II, Onium Capital LLC, Secured Transportation Services LLC, and Advan…
Ashland Inc. entered into a Second Amended and Restated Credit Agreement dated May 28, 2026, with multiple lenders including Bank of Nova Scotia, Citibank, and JPMorgan Chase. The …
Mission Produce has completed its acquisition of Calavo Growers, uniting two major North American avocado companies and expanding Mission's product portfolio into prepared foods an…
# FDA Approves Hikma's Generic Drug Application Hikma Pharmaceuticals received FDA approval for ANDA 220562 on May 29, 2026, expanding its generic drug portfolio and positioning t…
Novadoz Pharmaceuticals announced the FDA approval of its oral oxcarbazepine tablets (ANDA 209020), a generic version of the anticonvulsant, which is expected to bolster the compan…
Shionogi Inc. announced FDA approval for the oral antiviral XOCOVA (ensitrelvir) effective May 29, positioning the company to expand its commercial footprint with a non-injectable …
**Flex Pharma received FDA approval for NDA217379 on May 29, 2026, a milestone anticipated to unlock significant commercial value and drive a material re-rating of the company’s ma…
HAISCO PHARMACEUTICAL GROUP CO LTD has received FDA approval for its unspecified New Drug Application, setting the stage for a pivotal product launch in May 2026 that is expected t…
Cycurion Inc. has entered into a merger agreement to acquire Secuvant LLC, a Utah-based company with the Panoptic product line, for $875,000 in cash and 888,888 shares of Series I …